MedTrace Logo

Efficacy of Extracorporeal Shockwave Myocardial Revascularization

NCT01711099 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2012-10-25

No results posted yet for this study

Summary

Clinical research to justify effectiveness of the Extracorporeal Shockwave Myocardial Revascularization (ESMR) Therapy for treatment of patients with reversible myocardial ischemia secondary to Coronary Artery Disease (CAD) and therapy resistant stable angina pectoris.

Conditions

  • Refractory Angina Pectoris

Interventions

DEVICE

device for Extracorporeal Shockwave Myocardial Revascularization (ESMR) therapy

Sponsors & Collaborators

  • Salus Ltd.

    lead INDUSTRY

Principal Investigators

  • Béla Merkely, Prof · Semmelweis University Heart Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-09-30

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01711099 on ClinicalTrials.gov